EUVIMEDEUVIMED entdecken
Crossref

MiR‐155‐5p Inhibits Multiple Myeloma Cell Malignancy and Tumorigenesis by Targeting JARID2 and Inactivating the TGFβ/SMAD2 Signaling

Yuan Yuan, Tingting Zhang, Pingping Zhang iD, Lili Han iD, Jiajia Li iD, Shuxian Gao

Journal of Biochemical and Molecular Toxicology · 2025-06 · 39 (6)

DOI: 10.1002/jbt.70336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 09.06.2025. Verfasst von Yuan Yuan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China. Hauptthemen laut MEDLINE: MicroRNAs, Smad2 Protein, Multiple Myeloma, Transforming Growth Factor beta. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: This study was supported by the Infection and Immunity in Anhui General University Key Laboratory Departmental Key Laboratory Open Subjects (Bengbu Medical Uni….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) is a hematological malignancy characterized by the accumulation of malignant plasma cells in bone marrow and remains largely incurable. The study aimed to investigate the role of miR‐155‐5p in modulating malignant cellular behavior and tumorigenesis in MM. MiR‐155‐5p expression in MM tissues and cells was measured by RT‐qPCR. In the context of miR‐155‐5p overexpression, Transwell, wound healing, and CCK‐8 assays were conducted to evaluate cell invasion, migration, and viability, respectively. Xenograft tumor models were established to explore the influence of miR‐155‐5p and JARID2 on tumor growth in vivo. Gene interaction was analyzed using a luciferase reporter assay. Western blot analysis was carried out to quantify protein expression of JARID2 and components involved in the TGFβ/SMAD2 signaling pathway. Experimental results revealed that miR‐155‐5p expression was significantly diminished in MM cells and tissue samples. Overexpressing miR‐155‐5p not only suppressed MM cell viability, invasion, and migration but also restrained tumor growth. JARID2 was highly expressed in MM cells and identified as a direct target of miR‐155‐5p. In MM tissues, miR‐155‐5p expression was inversely correlated with JARID2 expression. Furthermore, JARID2 overexpression effectively reversed the inhibitory impacts of miR‐155‐5p on cell malignancy and tumorigenesis. In addition, miR‐155‐5p inactivated the TGFβ/SMAD2 pathway by negatively regulating JARID2 expression. In conclusion, miR‐155‐5p inhibits MM cell malignancy and tumorigenesis by targeting JARID2 and inactivating the TGFβ/SMAD2 signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsSmad2 ProteinMultiple MyelomaTransforming Growth Factor betaSignal TransductionCarcinogenesisPolycomb Repressive Complex 2RNA, NeoplasmGene Expression Regulation, NeoplasticNeoplasm ProteinsHumansAnimalsCell Line, TumorMiceMice, NudeFemaleMaleCell Movement

Stichwörter der Autor:innen

JARID2MiR‐155‐5pTGFβ/SMAD2multiple myelomaxenograft tumor

Substanzen

MicroRNAsSmad2 ProteinTransforming Growth Factor betaSMAD2 protein, humanMIRN155 microRNA, humanJARID2 protein, humanPolycomb Repressive Complex 2RNA, NeoplasmNeoplasm Proteins

Autor:innen und Institutionen

  • Department of Hematology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
  • Anhui Key Laboratory of Infection and Immunity, Bengbu Medical University, Bengbu, China.

ORCID-Profile: Pingping Zhang, Lili Han, Jiajia Li

Förderung

  • This study was supported by the Infection and Immunity in Anhui General University Key Laboratory Departmental Key Laboratory Open Subjects (Bengbu Medical Uni…

Zitieren

APA

Yuan, Y., Zhang, T., Zhang, P., Han, L., Li, J., & Gao, S. (2025). MiR‐155‐5p Inhibits Multiple Myeloma Cell Malignancy and Tumorigenesis by Targeting JARID2 and Inactivating the TGFβ/SMAD2 Signaling. Journal of Biochemical and Molecular Toxicology, 39(6). https://doi.org/10.1002/jbt.70336

Vancouver

Yuan Y, Zhang T, Zhang P, Han L, Li J, Gao S. MiR‐155‐5p Inhibits Multiple Myeloma Cell Malignancy and Tumorigenesis by Targeting JARID2 and Inactivating the TGFβ/SMAD2 Signaling. Journal of Biochemical and Molecular Toxicology. 2025;39(6). doi:10.1002/jbt.70336

BibTeX
@article{Yuan2025,
  author = {Yuan, Yuan and Zhang, Tingting and Zhang, Pingping and Han, Lili and Li, Jiajia and Gao, Shuxian},
  title = {MiR‐155‐5p Inhibits Multiple Myeloma Cell Malignancy and Tumorigenesis by Targeting JARID2 and Inactivating the TGFβ/SMAD2 Signaling},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  volume = {39},
  number = {6},
  doi = {10.1002/jbt.70336}
}
Kostenlos starten →